Notice for elasomeran (Moderna Australia Pty Ltd)
Active ingredients
elasomeran
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 12 years of age and older
Therapeutic area
Infectious diseases